XML 42 R32.htm IDEA: XBRL DOCUMENT v3.22.2
Stockholders’ Equity (Tables)
 6 Months Ended
Jun. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
The grant date fair value of the Company’s stock options granted (excluding the stock options granted to the CEO outlined above) was estimated using the following weighted average assumptions for the six months ended June 30, 2022:
 
Expected term (in years)6.02
Expected volatility47.8 %
Risk-free interest rate1.9 %
Expected dividend yield— %
Share-based Payment Arrangement, Option, Activity
Option activity (excluding the stock options granted to the CEO outlined above) is as follows (in thousands, except for weighted average exercise price and weighted average contractual term in years):
 
SharesWeighted
Average
Exercise
Price		Weighted
Average
Contractual
Period
(in Years)		Aggregate
Intrinsic
Value
Outstanding at December 31, 202110,401 $4.01 7.73$37,868 
Granted5,700 4.97 
Exercised (including early exercised options vested during the period)(1,172)1.32 
Forfeited and expired(394)6.33 
Outstanding at June 30, 202214,535 4.55 8.3618,347 
Exercisable as of June 30, 20228,138 3.41 7.4417,987 
Share-based Payment Arrangement, Option, Exercise Price Range
The options outstanding and exercisable as of June 30, 2022 (excluding the stock options granted to the CEO outlined above) have been aggregated into ranges for additional disclosure as follows (in thousands, except weighted average remaining contractual life and exercise price):
 
 Options OutstandingOptions Exercisable
Exercise PriceSharesWeighted Average Remaining Contractual Life 
(in Years)		SharesWeighted Average Remaining Contractual Life 
(in Years)
$ 0.06 – 0.40
1,882 5.711,882 5.71
1.55 – 1.75
1,480 6.941,409 6.94
2.43 – 3.11
3,061 8.002,946 7.93
5.01
5,583 9.66378 9.66
8.13 – 9.41
1,598 8.631,207 8.47
12.21 – 15.17
931 8.79316 8.73
14,535 8,138 
Share-based Payment Arrangement, Restricted Stock Unit, Activity
RSU activity is as follows (in thousands, except for weighted average grant date fair value):

SharesWeighted Average Grant Date Fair Value
Unvested at December 31, 20213,982 11.55 
Granted6,405 4.26 
Vested(992)10.27 
Forfeited and expired(277)9.71 
Unvested at June 30, 20229,118 $6.76 
Share-based Payment Arrangement, Expensed and Capitalized, Amount
The following table summarizes stock-based compensation expense for employees and nonemployees, by category, on the condensed consolidated statements of operations and comprehensive loss for the three and six months ended June 30, 2022 and 2021 (in thousands):
 
Three Months Ended June 30,Six Months Ended June 30,
2022202120222021
Marketing$1,072 $772 $1,895 $2,618 
Selling, general, and administrative9,560 8,388 17,593 40,772 
Total stock-based compensation expense$10,632 $9,160 $19,488 $43,390